Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Treatment of the bone marrow stromal stem cell supernatant by nasal administration—a new approach to EAE therapy

Fig. 1

BMSC supernatant ameliorated EAE clinical course. a The EAE model was established in C57BL/6 mice, intranasally administered with BMSC supernatant (BMSC supernatant group) or medium control (control group) from day 3 post immunization until clinical symptom appeared. b EAE clinical course (upper panel) and body weight (lower panel) of rMOG-induced EAE, mean ± SEM, n = 14, ***P < 0.001. c EAE clinical course (upper panel) and body weight (lower panel) of MOG35–55-induced EAE, mean ± SEM, n = 6

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512